...
首页> 外文期刊>Clinical Biochemistry >AgNORs count and DNA ploidy in liver biopsies from patients with schistosomal liver cirrhosis and hepatocellular carcinoma.
【24h】

AgNORs count and DNA ploidy in liver biopsies from patients with schistosomal liver cirrhosis and hepatocellular carcinoma.

机译:血吸虫性肝硬化和肝细胞癌患者肝活检中的AgNORs计数和DNA倍性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: Argyrophilic nucleolar organizer regions (AgNOR) proteins are a set of argyrophilic nucleolar proteins that accumulate in highly proliferating cells, whereas their expression is very low in nonproliferating cells. The present study aimed to investigate the potential of DNA flow cytometry (FCM) and AgNORs count in the assessment of cellular kinetics of liver cirrhosis and hepatocellular carcinoma. DESIGN AND METHODS: Small-needle liver biopsies (217) were included and were taken from 84 patients with hepatocellular carcinoma (HCC) (one biopsy from tumor lesion and the other from residual nontumor) liver tissues. Only one biopsy was taken from 49 patients with liver cirrhosis. One part of biopsy was subjected to flow cytometry, and the other, to histopathology and AgNORs counting. RESULTS: An aneuploidy was shown in 44.5% of liver cirrhosis and in 78.6% of tumor sites. Aneuploid HCC cases showed high AgNORs count compared with diploid cases (3.407+/-1.18 vs. 1.74+/-0.9). An extremely significant increase in AgNORs count in tumor lesion (P<0.001) was found compared with residual liver tissues, liver cirrhosis and normal liver (3.89+/-0.827, 1.49+/-0.52, 1.62+/-0.29, and 1.3+/-0.17, respectively). In liver cirrhosis, dysplasia showed a significant relationship with ploidy (P<0.001) and AgNORs count (P<0.05). CONCLUSION: AgNORs count and DNA ploidy analysis of core biopsy specimens are useful in the assessment of cellular kinetics of liver cirrhosis and hepatocellular carcinoma.
机译:目的:嗜银细胞核仁组织区蛋白(AgNOR)是一组嗜银细胞核仁蛋白,它们在高度增殖的细胞中积累,而在非增殖细胞中的表达却很低。本研究旨在调查DNA流式细胞仪(FCM)和AgNORs计数在评估肝硬化和肝细胞癌的细胞动力学方面的潜力。设计与方法:纳入小针肝活检(217例),取自84例肝细胞癌(HCC)(一次是从肿瘤病变活检,另一次是残留的非肿瘤活检)肝组织。 49例肝硬化患者仅进行了一次活检。活检的一部分进行流式细胞术,另一部分进行组织病理学和AgNORs计数。结果:非整倍体显示在肝硬化的44.5%和肿瘤部位的78.6%。与二倍体病例相比,非整倍体HCC病例显示较高的AgNORs计数(3.407 +/- 1.18对1.74 +/- 0.9)。与残留的肝组织,肝硬化和正常肝相比,肿瘤病变中的AgNORs计数显着增加(P <0.001)(3.89 +/- 0.827、1.49 +/- 0.52、1.62 +/- 0.29和1.3+ /-0.17)。在肝硬化中,异型增生与倍性(P <0.001)和AgNORs计数(P <0.05)显着相关。结论:核心活检标本的AgNORs计数和DNA倍体分析可用于评估肝硬化和肝细胞癌的细胞动力学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号